0.9% Sodium Chloride Solution, Glenzocimab clinical trials

GREEN A randomized, double-blind, multi-center, placebo-controlled, efficacity and safety study of glenzocimab used as an add-on therapy on top of mechanical thrombectomy for acute ischemic stroke

This study, called GREEN, is testing a new drug called glenzocimab for people who have had a stroke. It wants to see if adding glenzocimab to standard treatment helps patients recover better and quickly after their stroke. The study is checking how well it works and if it's safe.